Table 2.
Multivariate analysis. Factors independently associated with death occurring June–August 2020 compared to March–May 2020
| Variable | AOR | 95% Confidence Interval |
|---|---|---|
| Demographics | ||
| Age (per 1-year increment) | 1.050 | 1.027–1.073 |
| Female | 1.810 | 1.186–2.760 |
| Number of comorbiditiesa | ||
| 0 or 1 | Ref | – |
| 2 | 1.467 | 0.638–3.379 |
| 3 or more | 2.233 | 1.087–4.586 |
| Non-respiratory complications | ||
| Acute renal failure | 0.986 | 0.613–1.585 |
| Superinfection | 2.740 | 1.723–4.356 |
| Treatments | ||
| Antiviralsb | 0.307 | 0.196–0.479 |
| Steroids | 2.335 | 1.485–3.670 |
| Disease trajectory | ||
| Days from symptoms onset to death (per 1-day increment) | 1.065 | 1.054–1.076 |
AOR Adjusted Odds Ratio
a0 and 1 categories were merged due to the limited number of cases with 0 comorbidities in the June–August period (n = 1)
bIncluding hydroxychloroquine